Canadian specialty pharma company, Knight Therapeutics, reports Q1 record results – BNN Bloomberg

Skip to main content

ADVERTISEMENT

Morning Markets

Canadian specialty pharma company, Knight Therapeutics, reports Q1 record results

Samira Sakhia, president and CEO of Knight Therapeutics, joins BNN Bloomberg to discuss the company's Q1 results as their stock trends higher.

May 07, 2026 at 12:14PM EDT

Canadian specialty pharma company, Knight Therapeutics, reports Q1 record resultsOpens in new window

07:42 · May 07, 2026 at 12:14PM EDT

'We think there are some opportunities to be found in the software space': LlerenaOpens in new window

07:14 · May 07, 2026 at 12:10PM EDT

Suncor slides despite jump in Q1 earningsOpens in new window

07:18 · May 06, 2026 at 12:05PM EDT

Is now a good time to put more money into AI stocks?Opens in new window

06:00 · May 06, 2026 at 12:01PM EDT

RioCan blended leasing spreads 25.8% in Q1Opens in new window

07:59 · May 05, 2026 at 12:19PM EDT

Positioning for the space economyOpens in new window

06:22 · May 05, 2026 at 12:17PM EDT

Thomson Reuters Q1 beat in revenueOpens in new window

06:27 · May 05, 2026 at 12:04PM EDT

How much is tech driving returns right now?Opens in new window

06:49 · May 05, 2026 at 11:56AM EDT

Canada’s first CAD-backed stablecoin approvedOpens in new window

06:28 · May 04, 2026 at 1:20PM EDT

The Case for 'Jailbreaking' Tech in CanadaOpens in new window

06:26 · May 04, 2026 at 12:16PM EDT